Skip to main content


Submission concerning Dupixent for severe eczema - 16 May 2022

Submission from Allergy & Anaphylaxis Australia (A&AA):Dupixent for severe eczema. 

A&AA asks that you consider the changed lives of people with severe eczema who are now taking Dupixent in the July 2022 PBAC meeting.

People are utilising the medication because there has been a huge need for a treatment that works without the need for immunosuppressive medication.

People are sharing their stories and those who were disengaged are now re engaging with health professionals that can review their health condition and offer those with severe eczema this new treatment

pdfSubmission concerning Dupixent for severe eczema - 16 May 2022177.41 KB




If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.